Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy
(LVH), providing morphologic, functional, and often clinical information to clinicians …

Fabry disease (FD) is a rare, X-linked inherited disorder of glycosphingolipid metabolism. It
leads to the progressive accumulation of globotriaosylceramide within lysosomes due to a …

Importance Although myocardial injury can occur with acute COVID-19, there is limited
understanding of changes with myocardial metabolism in recovered patients. Objective To …

Cardiomyopathies (CMPs) are myocardial diseases in which the heart muscle is structurally
and functionally abnormal in the absence of coronary artery disease, hypertension, valvular …

Background Cardiac involvement is the leading cause of mortality in patients with Fabry
disease. Identification of imaging findings that predict adverse cardiac events is needed to …

Background Many individuals have persistent cardiac symptoms after mild COVID-19
infection. However, studies assessing the relationship between symptoms and cardiac …

Fabry disease (FD) is a rare, progressive, X-linked inherited disorder of glycosphingolipid
metabolism. It is a monogenic disease due to α-galactosidase A (α-GAL) enzyme deficiency …

The restrictive cardiomyopathies constitute a heterogeneous group of myocardial diseases
with a different pathogenesis and overlapping clinical presentations. Diagnosing them …

Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of
alpha-galactosidase causing lysosomal overload of sphingolipids. FD cardiomyopathy is …

Abstract Purpose of Review Left ventricular hypertrophy (LVH) is a common presentation
encountered in clinical practice with a diverse range of potential aetiologies. Differentiation …